Press release
Global Vascular Stents Market to Grow at a CAGR of 6.35% Through 2032, Driven by Cardiovascular Disease Burden, Technological Innovations, and Aging Population | DelveInsight
Global Vascular Stents Market
Vascular stents-small mesh tubes used to hold blood vessels open-are essential tools in interventional cardiology and vascular surgery. They are now being widely deployed in procedures such as percutaneous coronary intervention (PCI), carotid artery stenting, and peripheral vascular interventions. Technological innovations such as drug-eluting stents (DES), bioresorbable scaffolds, covered stents, and dual-therapy stents are helping reduce restenosis and improve long-term clinical outcomes.
Minimally invasive endovascular techniques are being increasingly preferred due to shorter recovery times, reduced hospital stays, and fewer complications compared to open surgery. This trend is further boosting the adoption of advanced vascular stents in both high- and middle-income countries.
DelveInsight's Vascular Stents Market Insights, Competitive Landscape, and Market Forecast - 2032 provides a comprehensive analysis of market drivers, challenges, and trends across major markets, including the US, EU4, the UK, Japan, and emerging economies. The report explores segmentation by stent type (e.g., coronary, peripheral, and neurovascular), materials, drug-coating technologies, and end-user settings.
Key players like Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, and others are shaping the market through strategic acquisitions, R&D investment, and regulatory milestones. As focus intensifies on personalized vascular care, next-generation stents with improved biocompatibility, imaging integration, and long-term patency are poised to drive the market's evolution well into the next decade.
Explore the latest trends and growth drivers in the vascular stents market-download your sample report now https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Vascular Stents Market Report
• The global vascular stents market was valued at USD 11.23 billion in 2024 and is projected to grow at a CAGR of 6.35%, reaching USD 18.28 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global vascular stents market during the forecast period.
• Notable vascular stents companies such as Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, and several others are currently operating in the vascular stents market.
• In June 2024, Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent System, an implantable device used to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the U.S. FDA.
• In January 2024, W. L. Gore & Associates, Inc. (Gore) announced FDA approval of a lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).
• In January 2024, Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announced that it had received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System. The device was intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.
To read more about the latest highlights related to the vascular stents market, get a snapshot of the key highlights entailed in the global vascular stents market report here https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Vascular Stents Overview
Vascular stents are small, expandable mesh-like tubes inserted into narrowed or blocked blood vessels to restore and maintain proper blood flow. Commonly used in the treatment of conditions such as coronary artery disease, peripheral artery disease, and carotid artery stenosis, these stents help prevent arteries from collapsing or re-narrowing after angioplasty. Vascular stents come in various forms-including bare-metal, drug-eluting, and bioresorbable stents-each designed to address specific clinical needs. With advancements in materials, coatings, and minimally invasive delivery systems, vascular stents have become critical tools in modern cardiovascular and endovascular therapies, significantly improving patient outcomes and procedural efficiency.
Vascular Stents Market Insights
North America is set to dominate the vascular stents market in 2024, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and the presence of leading market players. According to CDC data (2024), 4.9% of U.S. adults had coronary heart disease in 2022, while atrial fibrillation affected over 12.1 million people in 2023. Stroke incidence remains high, with over 795,000 cases annually. Rising rates of obesity, diabetes, and hypertension are fueling demand for vascular interventions like angioplasty, where stents play a critical role.
Public health campaigns like American Heart Month (February 2024) have also boosted awareness, early diagnosis, and treatment uptake. In addition, innovation is accelerating market growth-for example, in August 2024, Renata Medical received FDA approval for its Minima Growth Stent, designed for pediatric use with the ability to expand as the child grows. These trends underscore North America's continued leadership in the global vascular stents market.
To know more about why North America is leading the market growth in the Vascular Stents market, get a snapshot of the Vascular Stents market outlook here https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Vascular Stents Market Dynamics
According to the British Heart Foundation (2025), over 640 million people globally are living with heart and circulatory diseases, with coronary (ischemic) heart disease affecting an estimated 200 million. This condition, marked by narrowed or blocked coronary arteries, is a leading driver of the vascular stents market, as drug-eluting stents play a critical role in restoring arterial flow post-angioplasty.
In Europe, transluminal coronary angioplasties are widely performed, with Croatia (500.1 per 100,000), Germany (379.3), and Bulgaria (378.4) leading the rates, per EU data (2024). The rising number of these procedures continues to fuel demand for stents, especially advanced types like bioresorbable and drug-eluting variants.
Innovations are also accelerating market growth. In April 2024, Abbott's EspritTM BTK Everolimus Eluting Resorbable Scaffold System received FDA approval for chronic limb-threatening ischemia (CLTI), offering improved vessel healing and eventual scaffold dissolution.
While the growing cardiovascular disease burden and technological advancements are expected to drive market expansion through 2032, concerns around thrombosis, restenosis, and stringent regulatory processes may present moderate challenges.
Get a sneak peek at the vascular stents market dynamics @ https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Vascular Stents Market CAGR: ~6.35%
Key Vascular Stents Companies: Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, and others.
Vascular Stents Market Segmentation
Market Segmentation By Product Type: Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, and Others], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents and Thoracic Aortic Aneurysm Stents].
Market Segmentation By Type: Bare-Metal Stents and Drug-Eluting Stents.
Market Segmentation By Material: Metal and Polymer.
Market Segmentation By Mode of Delivery: Balloon-Expandable Stents and Self Expandable Stents.
Market Segmentation By End-User: Hospitals and Ambulatory Surgical Centers.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the vascular stents market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Vascular Stents Market Report Introduction
2. Vascular Stents Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Vascular Stents Market Key Factors Analysis
6. Vascular Stents Market Porter's Five Forces Analysis
7. Vascular Stents Market Layout
8. Vascular Stents Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Vascular Stents Market to Grow at a CAGR of 6.35% Through 2032, Driven by Cardiovascular Disease Burden, Technological Innovations, and Aging Population | DelveInsight here
News-ID: 4091609 • Views: …
More Releases from DelveInsight
Hypovolemia Pipeline Insight 2025: Next-Gen Volume Expanders, Oxygen Therapeutic …
DelveInsight's "Hypovolemia - Pipeline Insight, 2025" provides a comprehensive overview of the therapeutic innovations aimed at managing this life-threatening condition characterized by rapid loss of circulating blood volume. Often triggered by trauma, surgery, gastrointestinal bleeding, or obstetric emergencies, hypovolemia remains a critical care challenge due to limited availability of blood products, logistical hurdles in emergency settings, and complications associated with excessive crystalloid use.
The 2025 pipeline emphasizes the development of next-generation…
Abdominal Aortic Aneurysm (AAA) Repair Devices Market to Register a CAGR of 5.70 …
The global abdominal aortic aneurysm (AAA) repair devices market is poised for steady growth through 2032, supported by the rising prevalence of aneurysms among the aging population, lifestyle-related risk factors such as smoking and hypertension, and improved diagnostic detection rates. The increasing adoption of minimally invasive endovascular aneurysm repair (EVAR) devices over traditional open surgery is enhancing procedural safety, reducing hospital stays, and improving patient outcomes.
Moreover, advancements in stent graft…
Adult-Onset Still Disease Pipeline Insight 2025: IL-1/IL-6 Blockade, JAK Inhibit …
DelveInsight's "Adult-Onset Still Disease - Pipeline Insight, 2025" provides a detailed overview of the evolving therapeutic landscape for this rare systemic autoinflammatory disorder. Traditionally reliant on corticosteroids and conventional DMARDs, Adult-Onset Still Disease (AOSD) has long posed clinical challenges due to its relapsing course, systemic inflammation, and risk of complications such as macrophage activation syndrome.
The 2025 pipeline highlights the growing dominance of targeted biologics, particularly IL-1 and IL-6 inhibitors, which…
Laparoscopy Devices Market to Witness Robust Growth by 2032, Driven by Rising Mi …
The laparoscopy devices market is expected to grow steadily through 2032, driven by the increasing adoption of minimally invasive surgical procedures across gastrointestinal, gynecological, and urological specialties. Advances in high-definition imaging, robotic-assisted systems, and energy-based surgical tools are enhancing precision, reducing recovery times, and improving patient outcomes. Additionally, the rising prevalence of chronic diseases, growing geriatric population, and increasing awareness of minimally invasive surgery benefits are expected to further propel…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
